NRC program recharge in Human Health Therapeutics – Workshop at Life Sciences British Columbia

November 16, 2018 — Vancouver, British Columbia

The National Research Council of Canada's programs are being refreshed to incorporate a new collaboration model that includes grants and contributions (Challenge Programs), while its regular research programs will continue to provide innovative solutions to industry.

The recently announced Health Challenge Program is being scoped around the theme of engineered cell- and gene-based therapy development and delivery, in broad consultations with Canadian academia, hospitals and business communities. The NRC Health Challenge Program's three main research areas are: (1) next generation chimeric antigen receptors (CARs); 2) induced pluripotent stem cell (iPSC) technologies; and 3) in vivo genome editing.

Academia and industry are invited to attend a workshop at Life Sciences British Columbia on November 16, 2018 to provide the NRC's Human Health Therapeutics Research Centre with input into the program development and discuss future engagements.

Participants can register free of charge on the Life Sciences British Columbia event page.

Agenda

Time Topic Speaker

9:00 a.m.

Intro Presentation from Life Sciences British Columbia

Dr. Lesley Esford, President & CEO, LSBC

9:10 a.m.

Intro Presentation from the NRC

Eileen Raymond, Business Advisor, Business Management Support, NRC

9:15 a.m.

NRC Advanced Biologics and Biomanufacturing Program

The NRC is seeking new opportunities for co-development of biologics for cancer and CNS diseases, vaccines for unmet needs and enabling technologies

Dr. Lynne LeSauteur, R&D Director, Downstream Processing and Analytics, and Program Leader, Biologics and Biomanufacturing, NRC

9:35 a.m.

NRC Genomics Expertise and Deep Learning Approaches

The NRC is seeking to leverage its applied genomics expertise and capacities for gene- and cell-based therapy development

Dr. Simon Drouin, Team Leader, Applied Genomics, NRC

9:45 a.m.

Questions and networking break

10:15 a.m.

NRC Health Challenge Program: Transforming Health Outcomes through Engineered Cell and Gene Therapies

NRC is seeking to engage discussions on the collaborative opportunities for this program focusing on disruptive technologies applied to next generation of engineered cell and gene therapies

Dr. Danica Stanimirovic, Director of Translational Bioscience Department and Interim Program Director, NRC Health Challenge Program

10:45 a.m.

Open discussion and networking

 

11:30 a.m.

End of session

 

Date modified: